Evaluation of a procaspase-3 activator with hydroxyurea or temozolomide against high-grade meningioma in cell culture and canine cancer patients.
Tonogai EJ, Huang S, Botham RC, Berry MR, Joslyn SK, Daniel GB, Chen Z, Rao J, Zhang X, Basuli F, Rossmeisl JH, Riggins GJ, LeBlanc AK, Fan TM, Hergenrother PJ.
Tonogai EJ, et al. Among authors: daniel gb.
Neuro Oncol. 2021 Oct 1;23(10):1723-1735. doi: 10.1093/neuonc/noab161.
Neuro Oncol. 2021.
PMID: 34216463
Free PMC article.